M&A

Perrigo to sell generic drugs business for $1.55 billion
Reuters
Tue, 03/2/21 - 12:07 am
Perrigo
generics
M&A
Could Even More M&A Be on the Way for Hologic?
Medical Devices and Diagnostics Industry
Mon, 03/1/21 - 11:44 pm
devices
Holologic
M&A
Diagenode
Merck's OncoImmune COVID-19 Therapeutic Stuck at Starting Gate Pending Further Data
BioSpace
Sun, 02/28/21 - 10:16 pm
Merck
COVID-19
OncoImmune
M&A
FDA
Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche
Fierce Biotech
Thu, 02/25/21 - 10:44 am
Merck
Pandion
M&A
immune modulators
Amgen
Eli Lilly
Roche
The CRO megamerger is back as Icon snaps up PRA Health for $12B
Fierce Biotech
Wed, 02/24/21 - 10:56 am
M&A
CROs
Icon Biosciences
PRA Health
LSD biotech MindMed buys digital trial firm HealthMode
Pharmaforum
Fri, 02/19/21 - 10:25 am
MindMed
M&A
HealthMode
digital therapeutics
psychedelic drugs
Onduo takes its time
EP Vantage
Fri, 02/19/21 - 10:24 am
Onduo
Livongo
M&A
mobile apps
digital therapeutics
Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies
Biopharma Reporter
Thu, 02/18/21 - 10:43 am
Quotient
M&A
Arcinova
CDMOs
Humacyte sets out to bring regenerative medicine to Wall Street, then the world
MedCity News
Wed, 02/17/21 - 11:28 pm
Humacyte
SPAC
M&A
regenerative medicine
Exact Sciences-Guardant rivalry in colorectal testing market heats up
Medtech Dive
Wed, 02/17/21 - 11:23 pm
EXACT Sciences
Guardant Health
diagnostics
colorectal cancer
Ashion Analytics
M&A
Flow Acquires Halo Neuroscience to Develop Brain Stimulation Technology to Treat Depression
Xtalks
Wed, 02/17/21 - 10:53 am
neurotech
Flow Neuroscience
Halo Neuroscience
M&A
brain stimulation
mental health
neuromodulation
Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition
BioSpace
Wed, 02/17/21 - 10:51 am
Charles River Labs
Cognate BioServices
gene therapy
CDMOs
M&A
Quotient, buoyed by Covid-19 work, buys Arcinova in effort to build end-to-end CDMO brand
Endpoints
Thu, 02/11/21 - 10:31 pm
Quotient
Arcinova
M&A
CDMOs
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
Motley Fool
Thu, 02/11/21 - 10:56 am
Pfizer
M&A
BioNTech
Xeljanz
Biotech flotations offer venture funds an accelerating exit
EP Vantage
Thu, 02/11/21 - 10:39 am
biotech
IPOs
startups
M&A
A year after FTC nixed Illumina buyout, SoftBank bets $900M on PacBio's new vision
Endpoints
Wed, 02/10/21 - 10:24 am
Pacific Biosciences
Illumina
SoftBank
M&A
Nautilus set to go public in reverse merger with Perceptive SPAC, aims to test proteomics platform with big-name backers
Endpoints
Tue, 02/9/21 - 11:21 am
Nautilus Biotechnology
NASDAQ
SPAC
IPOs
reverse merger
M&A
Arya Sciences
How Bristol Myers Squibb's Celgene Buyout Continued to Pay Off in Q4
Motley Fool
Thu, 02/4/21 - 08:07 pm
Bristol-Myers Squibb
Celgene
earnings
M&A
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Stat
Wed, 02/3/21 - 10:58 am
Jazz Pharma
GW Pharma
M&A
CBD
epilepsy
Epidiolex
Vertex is poised for a shopping spree. But it’s still unclear just what might go into their basket — and at least one analyst is getting impatient
Endpoints
Tue, 02/2/21 - 10:27 am
Vertex Pharmaceuticals
M&A

Pages